cr for a company with essentially no debt

The only explanation for the ridiculous number of posts complaining about the CR and management that I can think of is that there are a great deal of either a)trolls b) angsty short term holders who do not fundamentally believe in either the products being developed or the management team running the company + probably did not sell out when they would have liked to.... Frankly I cannot see any issues at all...for the following reasons:

1. Cardiocel alone justifies higher prices than we are currently seeing (deff higher than 10c once sales figures start coming in)
2. The CR is to existing holders meaning there will be no broadening of the register
3. A CR for a company with no debt ultimately results in higher SP and reflects growth...
4. The CR is being partly underwritten by a well known investor...this personally gives me additional confidence in the company
5. Current SP will seem like a distant passed by Christmas/early in the new year

Just a few reasons for less teenage angst...

People need to chill...out

Madarch